Measures for clinical application of antineoplastic drugs-Trial

On December 30, the National Health Commission issued the administrative measures for the clinical application of anti-tumor drugs (for Trial Implementation). There are five chapters and 48 articles in the measures, which manage the whole process of selection, purchase, storage, prescription, deployment, clinical application and drug evaluation of anti-tumor drugs in medical institutions. Antineoplastic drugs are divided into restricted use level and common use level. The medical institutions shall formulate the Classification Management Catalogue of anti-tumor drugs, assess and grant doctors corresponding prescription rights, and doctors shall issue anti-tumor drugs of corresponding levels according to the authorized prescription rights. AccordingRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is CNY 10,000 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field